Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N-linked hyperglycosylation

This publication has 11 references indexed in Scilit:

• The oligosaccharides in a recombinant hepatitis B virus surface antigen (HBsAg) carrying the pre‐S2 region derived from yeast
  FEBS Letters, 1992
• Structural characterization of the N-glycans of a recombinant hepatitis B surface antigen derived from yeast
  Biochemistry, 1992
• Production of hepatitis B surface antigen (PreS2 + S) by high-cell density cultivations of a recombinant yeast
  Journal of Biotechnology, 1991
• Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens
  Vaccine, 1991
• Anti‐PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2+S vaccine
  Journal of Medical Virology, 1990
• [24] Regulated GAL4 expression cassette providing controllable and high-level output from high-copy galactose promoters in yeast
  Published by Elsevier ,1990
• Randomized Dose Range Study of a Recombinant Hepatitis B Vaccine Produced in Mammalian Cells and Containing the S and PreS2 Sequences
  The Journal of Infectious Diseases, 1989
• Production and immunological analysis of recombinant hepatitis B vaccine
  Journal of Infection, 1986
• Neutralization of Hepatitis B Virus Infectivity by a Murine Monoclonal Antibody: An Experimental Study in the Chimpanzee
  Journal of Medical Virology, 1985
• Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA
  Published by American Medical Association (AMA) ,1984